SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001144204-17-059853
Filing Date
2017-11-17
Accepted
2017-11-17 08:16:32
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3/A tv479829_s3a.htm S-3/A 391623
2 EXHIBIT 23.1 tv479829_ex23-1.htm EX-23.1 2475
3 GRAPHIC image_001.jpg GRAPHIC 15620
4 GRAPHIC image_002.jpg GRAPHIC 8235
5 GRAPHIC image_003.jpg GRAPHIC 13733
6 GRAPHIC image_004.jpg GRAPHIC 19916
  Complete submission text file 0001144204-17-059853.txt   474875
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-220942 | Film No.: 171209730
SIC: 2834 Pharmaceutical Preparations